Health
Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy – News-Medical.Net
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers,…
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies were presented recently at…
Continue Reading
-
Noosa News11 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General20 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General21 hours agoSharp rise in airfares push UK inflation higher in July
-
Business7 hours agoWhere next for the CBA share price?